New IOLs (intraocular lens) offer hope to severely short-sighted
This article was originally published in Clinica
A type of intraocular lens that is inserted in front of the natural lens may prove to be an effective alternative to current methods of treating severe myopia such as refractive surgery and other implantable lenses.
You may also be interested in...
As the coronavirus continues to spread, one of the big four global vaccines companies has committed itself to the fight.
Sweden’s mid-sized pharmaceutical company, Swedish Orphan Biovitrum, has expanded into hematology and strengthened its immunology business, growing its top and bottom lines in 2019.